|
⚲
|
| Keyboard |
| Caruso James V
✚
|
|
|---|---|
| CIK # | 0001202770 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001202770] | |
| 4 | [0001202770] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Novelos Therapeutics Inc | |
| Caruso James V |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Novelos Therapeutics Inc CLRB
Warrants · derivative
|
2025-07-02 | Buy | 10,000 | $0.01 | 100 |
|
Novelos Therapeutics Inc CLRB
Common Stock
|
2025-07-02 | Buy | 10,000 | $4.99 | 49,900 |
|
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
|
2025-02-14 | Grant | 900,000 | $0.00 | |
|
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
|
2024-06-14 | Grant | 900,000 | $0.00 | |
|
Novelos Therapeutics Inc CLRB
Common Stock
|
2023-12-08 | Grant | 40,596 | $0.00 | |
|
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
|
2023-06-23 | Grant | 261,000 | $0.00 | |
|
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
|
2023-01-17 | Grant | 261,000 | $0.00 | |
|
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
|
2022-01-25 | Grant | 1,419,000 | $0.00 | |
|
Novelos Therapeutics Inc CLRB
Common Stock
|
2021-03-04 | Buy | 5,100 | $1.70 | 8,670 |
|
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
|
2021-03-04 | Grant | 1,600,000 | $0.00 | |
|
Novelos Therapeutics Inc CLRB
Series A Warrants · derivative
|
2021-03-04 | Sell | 46,948 | $0.19 | 8,920 |
|
Novelos Therapeutics Inc CLRB
Common Stock
|
2020-12-28 | Buy | 37,037 | $1.35 | 50,000 |
|
Novelos Therapeutics Inc CLRB
Common Stock
|
2020-06-05 | Buy | 21,740 | $1.15 | 25,001 |
|
Novelos Therapeutics Inc CLRB
Series H Warrants · derivative
|
2020-06-05 | Buy | 10,870 | $0.01 | 109 |
|
Novelos Therapeutics Inc CLRB
Common stock
|
2020-02-03 | Grant | 100,000 | $2.71 | 271,000 |
|
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
|
2019-01-17 | Grant | 75,000 | $0.00 | |
|
Novelos Therapeutics Inc CLRB
Common Stock, par value $0.00001 per share
|
2018-11-30 | Buy | 1,000 | $2.28 | 2,280 |
|
Novelos Therapeutics Inc CLRB
Stock option (right to buy) · derivative
|
2018-10-12 | Grant | 150,000 | $0.00 | |
|
Novelos Therapeutics Inc CLRB
Common Stock
|
2018-03-12 | Sell | 34,000 | $1.20 | 40,800 |
|
Novelos Therapeutics Inc CLRB
Common stock
|
2017-04-18 | Grant | 200,000 | $0.00 | |
| showing 20 of 27 most recent transactions | |||||